Aurolab Trust Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Aurolab Trust Pharmaceutical Export Portfolio Dataset — 4 Products, $2.7M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Aurolab Trust — Pharmaceutical Exporter Profile (2026) | 4 Products, $2.7M Trade | TransData Nexus

Product Portfolio — Top 4 by Export Value

Aurolab Trust exports 4 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Prednisolone	Respiratory	$1.5M	195	1.6%	12
2	Moxifloxacin	Advanced Antibiotics	$806.3K	192	2.5%	7
3	Gatifloxacin	Advanced Antibiotics	$246.1K	30	30.7%	2
4	Chondroitin	Nutritional Supplements	$153.7K	36	3.0%	8

Aurolab Trust exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $2.7M. The top category is Respiratory (55.4% of portfolio), followed by Advanced Antibiotics (38.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Aurolab Trust — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

Aurolab Trust, established in July 1992, is a non-profit charitable trust headquartered in Madurai, Tamil Nadu, India. It operates as a medium-sized enterprise, focusing on the manufacturing of ophthalmic consumables, including intraocular lenses (IOLs), surgical sutures, and pharmaceutical products. The trust is an integral part of the Aravind Eye Care System, a globally recognized network dedicated to providing quality eye care.

The trust's mission is to make modern ophthalmic technologies affordable and accessible, particularly in developing countries. By engineering high-quality products at a fraction of the cost of imported alternatives, Aurolab Trust has significantly contributed to reducing needless blindness worldwide.

2Manufacturing Facilities

Aurolab Trust's manufacturing facility is located in Madurai, Tamil Nadu, India. The plant specializes in the production of ophthalmic consumables, including IOLs, surgical sutures, and pharmaceutical products. The facility adheres to stringent quality assurance measures, complying with US FDA, EU GMP, and WHO GMP norms, ensuring the production of high-quality products.

3Key Leadership

The leadership team at Aurolab Trust includes:

Mr. R.D. Thulsiraj: President of Aurolab Trust and Director of Operations at the Aravind Eye Care System.

Dr. S. Aravind: Secretary of Aurolab Trust and Director of Projects at the Aravind Eye Care System.

Dr. P. Namperumalsamy: Trustee of Aurolab Trust and Chairman Emeritus of the Aravind Eye Care System.

Dr. G. Natchiar: Trustee of Aurolab Trust and Director Emeritus of the Aravind Eye Care System.

Dr. R. Kim: Trustee of Aurolab Trust and Director of IT & Technology at the Aravind Eye Care System.

Dr. N. Venkatesh Prajna: Trustee of Aurolab Trust and Director of Finance at the Aravind Eye Care System.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Aurolab Trust Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Aurolab Trust's products are exported to over 150 countries, including the United States, European Union, United Kingdom, Australia, and Japan. The trust's manufacturing facilities comply with international standards, including US FDA, EU GMP, and WHO GMP norms, facilitating market access in these regulated regions. While specific regulatory filings and approvals are not publicly disclosed, the adherence to these standards indicates a commitment to meeting the requirements of these markets.

2Emerging Markets

Aurolab Trust has a significant presence in emerging markets, particularly in Africa, Latin America, and Southeast Asia. The trust's products are exported to countries such as the Philippines, Indonesia, Uganda, Tanzania, Sri Lanka, Brazil, South Sudan, Zimbabwe, Bangladesh, Ivory Coast, Kenya, and Malawi. The trust's adherence to WHO GMP standards supports its ability to access these markets, as WHO prequalification is often a prerequisite for entry into many developing countries.

3Geographic Strategy

Aurolab Trust's geographic strategy focuses on diversifying its market presence across both developed and developing regions. By exporting to over 150 countries, the trust mitigates concentration risk and leverages opportunities in various markets. The emphasis on emerging markets aligns with the trust's mission to make quality eye care solutions accessible globally, particularly in regions with high unmet needs.

Aurolab Trust — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

While specific details regarding FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not publicly available, Aurolab Trust's compliance with US FDA standards indicates a commitment to meeting the regulatory requirements for the US market. The trust's adherence to international quality standards, including US FDA norms, supports its ability to export products to the United States.

2WHO & EU GMP

Aurolab Trust's manufacturing facilities comply with WHO GMP standards, ensuring the production of high-quality ophthalmic consumables. This compliance facilitates market access in countries that require WHO prequalification for medical products. Additionally, the trust's adherence to EU GMP norms supports its ability to export products to European markets.

3CDSCO & Indian Regulatory

As a manufacturer based in India, Aurolab Trust operates under the regulations of the Central Drugs Standard Control Organisation (CDSCO). The trust's compliance with international quality standards, including WHO GMP, indicates adherence to CDSCO requirements for manufacturing and exporting pharmaceutical products.

Aurolab Trust — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Aurolab Trust operates in a competitive landscape with several key players in the ophthalmic consumables market. Competitors include Appasamy Associates, Zeiss India, and Devine Meditech. While specific market share data is not publicly available, Aurolab Trust's extensive product portfolio and adherence to international quality standards position it as a significant player in the global market.

2Key Differentiators

Aurolab Trust's key differentiators include its non-profit status, which allows for the provision of high-quality ophthalmic consumables at affordable prices, and its integration within the Aravind Eye Care System, a globally recognized network dedicated to quality eye care. The trust's commitment to innovation and adherence to international quality standards further distinguish it in the market.

3Strategic Position

Aurolab Trust's strategic direction focuses on providing affordable and accessible ophthalmic solutions globally. The trust's expansion into related healthcare areas, such as cardiovascular sutures and antiseptics, leverages existing capabilities and aligns with its mission to address a broader range of medical needs. The future outlook includes continued innovation and expansion into both developed and developing markets.

Buyer Due Diligence Brief — Evaluating Aurolab Trust as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Aurolab Trust has a track record of consistent export volume, with shipments to over 150 countries, indicating reliability in meeting international demand. The trust's adherence to international quality standards, including US FDA, EU GMP, and WHO GMP norms, serves as reliability indicators, ensuring the production of high-quality ophthalmic consumables.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and compliance:

FDA Registration: Confirm the facility's registration with the US FDA.

WHO GMP Certification: Verify compliance with WHO Good Manufacturing Practices.

EU GMP Certification: Ensure adherence to European Union Good Manufacturing Practices.

Frequently Asked Questions — Aurolab Trust

How many pharmaceutical products does Aurolab Trust export from India?

Aurolab Trust exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Prednisolone ($1.5M), Moxifloxacin ($806.3K), Gatifloxacin ($246.1K), Chondroitin ($153.7K). Total export value is $2.7M.

What is Aurolab Trust's total pharmaceutical export value?

Aurolab Trust's total pharmaceutical export value is $2.7M, based on 453 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Aurolab Trust cover?

Aurolab Trust exports across 3 therapeutic categories. The largest are Respiratory (55.4%, 1 products), Advanced Antibiotics (38.9%, 2 products), Nutritional Supplements (5.7%, 1 products).

Get Full Aurolab Trust Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.

Aurolab Trust

Aurolab Trust — Export Portfolio & Destination Treemap

Who is Aurolab Trust? — Company Overview & Market Position

What Does Aurolab Trust Export? — Product Portfolio Analysis

Top Products by Export Value

Aurolab Trust Therapeutic Categories — 3 Specializations